In vitro and in vivo mechanism of hepatocellular carcinoma inhibition by beta-TCP nanoparticles
Langlang Liu, Honglian Dai, Yanzeng Wu, Binbin Li, Jiling Yi, Chao Xu, Xiaopei WuState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan, People’s Republic of ChinaBackground: Studies have showed that nanoparticles have a ce...
Guardado en:
Autores principales: | Liu L, Dai H, Wu Y, Li B, Yi J, Xu C, Wu X |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c95466716704ebcb5f3bc9693b8a5bf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of mitochondrial iron uptake in HepG2 cells
por: MAZARIEGOS,DORA INÉS, et al.
Publicado: (2006) -
Silver-doped graphene oxide nanocomposite triggers cytotoxicity and apoptosis in human hepatic normal and carcinoma cells
por: Ali D, et al.
Publicado: (2018) -
Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier
por: Lv Y, et al.
Publicado: (2017) -
In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine
por: Li S, et al.
Publicado: (2017) -
Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells
por: Yuan Y, et al.
Publicado: (2019)